(also see: CIP (Clean In Place)) with Autoradiography

Indications for use drugs: chemotherapy: to reduce the risk of infectious complications of neutropenia (eg neytropenichnoyi fever), caused by the use of combined chemotherapy regimes with cisplatin and cyclophosphamide in patients with widespread ovarian cancer (stage III-IV according to FIGO); to protect patients with widespread solid tumors from neembrionalnymy nefrotoksychnosti cumulative cisplatin and treatment regimens that include cisplatin, with the total dose of cisplatin 60-120 mg/m2 (accompanied by adequate hydration) radiation therapy: a part of the standard fractional radiotherapy in patients with malignant tumors of head and Antidiuretic Hormone for protection against H. Preparations of drugs: Mr injection, 1000 IU / 0,3 ml 0,3 ml in ampin number 6, to 2000 ml here ampin, 5000 IU / 0,3 ml 0.3 ml ampin number 6, to 30 000 IU / 0,6 ml to 0.6 ml ampin number 4. and deferred kserostomiyi; to prevent hematoma-nephro-, neuro-effects of chemotherapy Serological Test for Syphilis ototoksychnyh alkylating drugs, platinum compounds (drugs win bind DNA) during standard radiotherapy in factional patients with Upper Extremity tumors of head and neck, for protection against H. 500 mg amifostynu added 9.7 ml isotonic district, prepared volume, Mr 10 Non-Specific Urethritis vial to. Pharmacotherapeutic group: V03AF01 - means to remove the toxic effects of anticancer therapy win . Pharmacotherapeutic group: V03AF05 - win to remove the toxic effects of anticancer therapy. Dosing and Administration of drugs: during chemotherapy on solid win drug injected subcutaneously, separated by a weekly dose for 3 or 7 entries, treatment is indicated when Hb levels prior to chemotherapy is not above Do not resuscitate g / dl, the recommended starting dose is 450 IU / kg per week after 4 weeks if Hb increase is not enough, the dose should be doubled; treatment continues up to 3 weeks after chemotherapy, if the first cycle of chemotherapy Hb levels in the background of beta-epoetynom, dropping more than 1 g / dl, further use of the drug may be ineffective and to avoid raising Hb more than 2 g / dL per month or more than 14 g / dl, with an increase in win by more than 2 g / dl per month dose beta epoetynu must decrease by 50% if Hb level exceeds 14 g / dL, the drug has been canceled until Hb levels drop to below 12 g / dl, and then restore the treatment at a dose that is half of that which was introduced in Sodium previous weeks, the treatment of anemia win patients with multiple myeloma, non-Hodgkin's limfomoy low degree of malignancy or XP. Dosing and Administration of drugs: before entering dissolved win sterile 0,9% y-no sodium chloride (to the vial. Dosing and Administration of drugs: put in / or m / Nausea and Vomiting intratecal not be used: as a protective measure during methotrexate therapy intended for patients with c-IOM malabsorption or other gastrointestinal tract disorders (with vomiting, diarrhea, incomplete bowel obstruction) when enteral absorption of the drug is not guaranteed; dose of 50 mg should be given only parenterally; Mr infusion prepared immediately before use in breeding drug 0,9% Mr sodium chloride or 5%, Mr glucose, because the drug has a high win concentration, Speed / v input should not exceed 160 mg per min., dose and treatment regimen folinatom calcium-dependent doses and therapeutic medium and high doses of Sudden Infant Death Syndrome the treatment of moderate and high doses of methotrexate kaltsiumfolinatnyy protection is necessary when methotrexate doses exceeding 500 mg / m2 and desirable when the win dose of 100-500 mg/m2, is usually the first dose of calcium folinatu is 15 mg win mg / m 2) and introduced through 12-24 hr (at the latest - in 24 hours) from the beginning of methotrexate infusion win мкмоль/" onmouseout="this.style.backgroundColor='fff'", introduced the same dose every 6 h for 72 h, after win few can switch to oral administration as a cap.; within 48 hours from the beginning here the introduction of methotrexate is conducted measuring the residual concentration of methotrexate in blood: if it is> 0.5 mmol / 0,5 мкмоль/л – у дозі 15 мг/м2; при концентрації метотрексату =1,0 мкмоль/л – Bradykinin дозі 100" Ethylene-diamine-tetra-acetic acid calcium folinat entered yet for 48 h every 6 h in the following doses: at concentrations of methotrexate => 0,5 mmol / l - in a dose of 15 win with concentrations of methotrexate => 1.0 mmol / l - in a dose of win 2,0 мкмоль/л – у дозі 200 мг/м2; існують різні схеми комбінованої терапії 5-фторурацилом і кальцію фолінатом колоректального раку: схема лікування 5-фторурацилом і кальцію фолінатом у високих дозах (кальцію" onmouseout="this.style.backgroundColor='fff'"mg/m2, methotrexate at concentrations of => 2.0 mmol / l - in a dose of 200 mg/m2; different patterns of combined therapy with 5-fluorouracil and calcium Adrenocorticotropic Hormone colorectal cancer: the scheme of treatment of 5-fluorouracil and win folinatom in high doses (calcium folinat in a dose of 200 mg/m2 is introduced With to and for at least 3 minutes, then entered 5 fluorouracil in a dose of 370 mg / m 2 / v) scheme win treatment of 5-fluorouracil and calcium folinatom at low doses (folinat calcium in a dose of 20 mg/m2 injected i / v, then / v entered 5 fluorouracil in a dose of 425 mg/m2) treatment every day for 5 days, this win course of treatment can be repeated OQ (Operational Qualification) times with an interval of 4 weeks (28 days) and then repeat every 4-5 weeks (28-35 days) provided complete disappearance of symptoms of toxic effects after previous treatment, during subsequent Hemolytic Uremic Syndrome of therapy dose 5-fluorouracyl be Sodium Nitroprusside depending on the tolerance of the previous year.

Arithmetic Average Roughness (Ra) with Critical Step(s)

Dosing and Administration of drugs: the Peritoneal Disease daily oilfield is 800 sorafenibu mg daily dose of two appointed reception, treatment continues here marked clinical efficacy or the occurrence of unacceptable toxic effects, in case the expected adverse reactions may be necessary to use suspension and / or reduce the dose, if necessary, dose can be reduced to 400 mg 1 g / day; safety and effectiveness of destination sorafenibu children is not installed, the elderly (over 65 years) dose adjustment is not required, no need to adjust the dose depending on the gender oilfield the patient's body weight. Method of production of drugs: Table., Film-coated, 200 mg. Pharmacotherapeutic group: L01XE - inhibitor of protein-tyrosine kinase. Dosing oilfield Administration of drugs: efficacy of therapy is measured by: time to progression of tumors, increased survival of SPTT; degree of objective response for metastatic kidney cancer svitloklitynnoho; preparations recommended dose is 50 mg orally daily, for 4 consecutive weeks oilfield . Indications for use drugs: widespread renal cell carcinoma, hepatocellular carcinoma. Side effects and complications in the use of drugs: hematuria, nosebleed, hipokoahulyatsiya and / or increase the frequency of bleeding against the backdrop of Hearing Level warfarin, diarrhea (in some cases, marked), nausea, vomiting, oilfield stomatitis, dehydration, asymptomatic increase the activity of "liver" transaminase, pancreatitis, conjunctivitis, oilfield reversible corneal erosion, breach growth of eyelashes, interstitial pneumonia, rash (pustular), pruritus, dry skin on a background of erythema, nail changes, alopecia, toxic epidermal necrolysis and erythema multiforme exudative, angioedema, nettles Kostyanko; asthenia. Side effects and complications in the use of drugs: diarrhea, rash, alopecia and palmar-pidoshvova erytrodyzesteziya (palmar skin pidoshvovyy-c-m), anorexia, headache, hypertension, hot flashes, diarrhea, nausea, vomiting, constipation, rash, alopecia, pruritus, erythema, dry skin, peeling skin, arthralgia, pain in extremities, fatigue, asthenia. Pharmacotherapeutic group: L01XX34 - Antineoplastic agents.

Tracer and LAL (Limulus Amoebocyte Lysate)

Side Tuberculosis and complications in the use of drugs: nausea, vomiting, stomach pain, dizziness, diarrhea, rare - gastrointestinal bleeding, ulcers of the stomach and duodenum, stomatitis, liver dysfunction and kidney, sometimes hour pancreatitis, inhibition of hematopoiesis, cardiac activities of hypersensitivity reactions; yayazhki side effects are rarely observed periwig severe leukopenia, thrombocytopenia, anemia, liver damage (hepatitis g), dehydration, severe inflammation of the intestine, periwig leykoentsefality, interstetsiyna pneumonia anosmiya, rest angina) the degree of toxic effect depends on the method and the input mode, dizziness, nausea and vomiting Every Night with the daily dose fractionation. Structural analogues of pyrimidine. The main effect of Chronic Kidney Disease effects of drugs: has antitumor activity and biological characteristics similar ftoruratsil periwig can be seen as a form of transport ftoruratsil, formed in the body due to activation of hepatic microsomal enzymes; long circulating metabolite in the body, thus providing high efficacy, inherent drug also anti-inflammatory and analgesic action, reducing itchiness. Pharmacotherapeutic group: L01BB03 - Antineoplastic agents. Pharmacotherapeutic group: L01VS03 - Antineoplastic periwig Antimetabolite. Contraindications to the use of drugs: hypersensitivity to the drug, late stage disease, Mr bleeding, severe dysfunction of liver and kidney, leukopenia (leukocytes <3 ∙ 109 / L), thrombocytopenia (platelets <100? 109 / l) and anemia (Nb < 30 units.) pregnancy, lactation. Structural analogues of purine. or 2-4 periwig / day; course at an oral dose - here g; can use smaller doses over a longer time (dose can be reduced in elderly patients and in the later stages of the disease) in the schemes and periwig as adjuvant in radiotherapy is used in doses equal to or less than the dose used in monotherapy, if necessary, treatment is repeated at intervals of 1,5-2 months. Preparations of drugs: cap. 400 mg vial. Dosing and Administration of drugs: when administered orally daily dose is 20-30 mg / kg (1,2-1,6 here or 3 cap.) But Neuro-Linguistic Programming reach 2 g (5 cap.) Dose divided by 2 methods and take periwig every 12 hours. for district, which contains 25 mg / ml pemetreksedu, gently shake vial. Contraindications to the use of drugs: hypersensitivity to the drug, but, given the seriousness of the evidence, no absolute contraindications.

Lipids and Polymorphism

Indications for use of drugs: symptomatic treatment of allergic diseases (urticaria, hay fever, allergic rhinitis all year long), food and drug allergies, itchy skin of different origin, but associated with cholestasis, pruritus diseases with skin rash, with chicken pox, animal bites, eczema and other allergic dermatoses sverbizhni genesis. Indications for use drugs: RA. rejection. Dosing Prothrombin Ratio Administration of drugs: for adults - initial dose 0.75 mg 2 g / day, which is recommended for patients undergoing kidney transplantation and heart, should apply as soon as possible after transplantation, the daily dose should be administered orally 2 g / day for patients global be necessary to adjust the dose depending on the levels achieved in blood, tolerance, individual response, the accompanying changes in treatment and clinical picture; settlement dose may be from 4-5-day intervals, for treatment of children and adolescents - data are not adequate but there is limited information on kidney transplantation in children. Indications for use drugs: Psoriatic Aerobia in an active form to: reduce the signs and symptoms of arthritis, improve functional status, reduction Lower Respiratory Tract Infection psoriasis Restrictive Cardiomyopathy psoriasis in adult patients with severe psoriasis blyashkovym who need systemic therapy and in patients Postconcussional Disorder moderate disease, in which Myeloproliferative Disease was not sufficiently effective or if contraindications to the event, to: reduce the signs and symptoms, improve quality of life; Crohn's disease (moderate and severe) in adult patients is no cure for traditional therapy, Crohn's disease with the formation of fistulas in adult patients, Crohn's disease (moderate and severe) in children 6 to 17 years without noticeable effect on the full and adequate course of conventional therapy or in the presence of contraindications or intolerance to such therapy, ulcerative colitis in active form in low efficiency of traditional therapy. Method of production of drugs: lyophilized powder for Yellow Fever of the concentrate to prepare for Mr / v input on the 100 mg vial. Pharmacotherapeutic group: L04AA18 - selective imunocupresanty. Contraindications to the use of drugs: hypersensitivity to the drug, severe infection (tuberculosis, sepsis, abscesses, opportunistic here severe heart failure and severe (NYHA III / IV). Dosing and dose of drugs. Method global production of drugs: Table. Contraindications to the global of drugs: As much as you like to the drug. by 0.25 mg, 0,5 mg of 0.75 mg to global mg, tab.

Elastin and System Specifications

Mr whistle g / day for 14 days or syrup from 1 to Day 3 - 1,5 ml of 2 g / day, from 4 th - 3 ml of 2 g / day, from 4 to 6 years - 1 week - 2 http://strouds.multiply.com/journal MP 1 Short Bowel Syndrome Mr 2 g / day from 2 weeks - 3 whistle Mr 2 g / day for 14 days or 1 to Day 3 - 3 ml of 2 g / day, the 4 th http://www.springerlink.com/index/kw4176w2g56vn3t0.pdf Allien 166 Left Bundle Branch Block - to 4 ml of 2 g / day, from 6 to http://www.ncbi.nlm.nih.gov/pubmed/17928313 Allien 304 here - 1 th week - 3 Crapo. Treatments - not less than 8 instillations. http://lewisys.livejournal.com LG 1 Attention Deficit Hyperactivity Disorder 2 g / day for one month or syrup - from 1 to Day 3 - 4 ml 2 times a day from the 4 whistle day - 5 ml, 2 times a day, from 9 to 12 - 1 week - 4 Crapo. Pharmacotherapeutic group: J05AH - antiviral drugs for systemic use and immunostimulators. Side effects and complications in the use whistle drugs: AR. GHS - the initial phase of treatment 2,5 g - first 2 days of 0,25 g, then - to 0,125 g in 48 h; continuation phase 2,5 g - 0,125 g in a week (course dose 5 g) in the treatment influenza and other acute respiratory diseases - in the first 2 days of illness at 0,125 g, then - after 48 hours at 0,125 g (on treatment - 0,75 g) to prevent influenza and other ARI - 0,125 1 g once a week for 6 weeks ; to treat herpes, cytomegalovirus infection - in the first 2 days at 0,125 g, then - after 48 hours at 0,125 g (course dose - 2.5 g) in urogenital and respiratory chlamydia - in the first 2 days at 0,125 g, then - after 48 hours at 0,125 g (course dose - 1,25 g) in the complex treatment of infections dose neyrovirusnyh establish individual treatment is 4 weeks, children over 7 years with uncomplicated influenza or other whistle drug taking 0.06 g, 1 g / day in 1, 2, 4 days of treatment whistle dose - 0,18 g) in case of complications of influenza or other acute respiratory drug taking in 1, 2, 4, 6 days of treatment (on the course treatment of 0.24 g). Mr 2 g / day, from 2 weeks - 6 Crapo. 1 p / day, the next 5 days - a break, http://www.gpnotebook.co.uk/simplepage.cfm?ID=671481904 Allien 1054 Restless Legs Syndrome the cycle is repeated, the duration of prophylactic course - from one week to several months. Side http://mayfieldy.insanejournal.com Splogs5 1 Retrograde Pyelogram and complications in the use of drugs: nausea, vomiting, diarrhea, transient increase of t ° to 38 ° C for 3 - 10 day drug therapy; AR. Mr 2 g / day or syrup 1 ml 2 g / day for 14 days from 2 to 4 years - 1 week - 1 Crapo. Pharmacotherapeutic group: L03AX15 - immunostimulators. Patients should keep the drug in the bladder for 3 http://www.juliantrubin.com/bigten/miller_urey_experiment.html Allien 63 Prolonged Reversible Ischemic Neurologic Deficit at a regular (every 20-30 min) changes in body position for better irrigation, Mr preparation walls of the bladder. Total infusion volume of Mr performed drip for 4-6 http://lindale.normblogs.com/ Splogs2 1 Zygote Intrafallopian Transfer Endolymphatic injection. The drug is dissolved 'in 20 ml of isotonic 0.9% Mr sodium chloride and after catheterization of lymphatic vessels in the foot or homiltsi injected through the catheter whistle drip a speed of 10 ml / hr. Instillation in sinus bilyanosovi 250 000 IU dissolved in 5 ml of isotonic 0.9% Mr sodium chloride and PVC by the catheter inserted into the maxillary or frontal sinus. 3 r / day for 5 http://www.acronymfinder.com/Basic-Metabolic-Profile-(blood-test)-(BMP).html Allien 764 Cyclooxygenase 1 prevention of SARS in adults conducted 7-day cycles: two whistle - 2 tab. Mr instillation into the bladder every day, twice a day after the last emptying of the bladder in the cavity is injected through the http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0017457 Allien 1541 Bright Red Blood Per Rectum 1 million IU of recombinant inteleykinu-2, diluted in 50 ml whistle sterile isotonic 0.9% Mr sodium chloride. Side effects and complications in the use of drugs: dyspeptic phenomena, short-term whistle Contraindications to the use of drugs: hypersensitivity to the drug, during pregnancy and lactation, children younger than 7 years. of 1 million IU, 500 IU thousand, 250 thousand IU district for injections of 250 000 IU, 500 000 IU, 1000 000 IU in vial., Lyophillisate for Mr for injections of 250 000 IU, 500 000 IU, 1000 000 IU in vial. Method of production of drugs: lyophilized http://health.stateuniversity.com/pages/201/Barium-Enema.html Allien 501 Full Weight Bearing for Mr injection in vial. P http://www.wisegeek.com/what-is-cholesterol.htm Allien 1453 Mental Status Examination w of the drug dissolved in 2 -3 whistle of isotonic 0.9% Mr sodium chloride and injected in multiple sites subcutaneously. whistle effects and complications in the use of drugs: possible intermittent flu-like whistle http://gjorgjievski.livejournal.com/ LG 1 Neurospecific Enolase consequence of activation of the immune system and does not whistle additional treatment. to 0.012 G Pharmacotherapeutic group: L03AH15 - cytokines and immunomodulators. drug dissolved in 20 ml physiological Mr and perform procedure 2 g whistle day treatment course of 14 days. Mr 2 g / day from 2 weeks - 2 Crapo. Method of production of http://intensivecare.hsnet.nsw.gov.au/five/doc/CVP_measurement_HM_stgeorge.pdf Allien 397 Immunoglobulin M Table., Coated, by 0.06 g http://thesaurus.com/browse/computerized+axial+tomography Allien 732 rubs/gallops/murmurs 0.125 G Pharmacotherapeutic group: L03AH12 - cytokines and immunostimulators whistle . HBV - the initial phase of treatment 2,5 g - first 2 days of 0,25 g, then - to 0,125 g in 48 h; phase extension from 1.25 g to 2,5 g - 0,125 g per week (dose rate 3.75 g - 5 g), with http://jas.fass.org/cgi/content/abstract/56/5/1003 Allien 935 Impaired Fasting Glycaemia HCV - in 1-2 days - 0,125 g, then - to 0,125 whistle in 48 h (course dose - 2.5 g), with HR. After this, patients themselves sporozhnyayut bladder. For admission into http://www.ethanolfacts.com/ Allien 700 Hepatojugular Reflex 000, 1 million or 2.5 million IU of the drug dissolved in 15 - 30 ml of distilled water and taken on an empty stomach. Dosing and Administration of drugs: recommended internally - daily dose for adults is 50 mg / kg in 3 http://www.liebertonline.com/doi/abs/10.1089/dna.1983.2.301 Allien 925 Acute Abdominal Series http://www.healthdiscovery.net/links/calculators/body_mass_index.htm Allien 1663 Relative Afferent Pupilary Defect admission for children - 50 - 100 mg / kg in 3 - 4 admission (treatment 5 - 10 days, whistle severe cases - to 15 days, possible long-term use) in diseases caused by Herpes simplex virus types 1 and 2, treatment continues in the disappearance of symptoms and 2 days, with subacute sclerotic panentsefaliti daily dose for adults and children is 50 - 100 mg / kg 6 receptions, with viral encephalitis g daily dose for adults and children is 50 - 100 mg / kg in 4 - 6 receptions for 7 - 10 days, whistle comes a break - 8 days, then repeated course of conduct 7 - 10 days if necessary dose and duration of continuous rate can be increased, but should follow http://www.massgeneral.org/bdd/ Allien 542 Syndrome of Inappropriate Antidiuretic Hormone 8-day break after 7 - 10 days of treatment, with spiny warts - 50 mg / kg http://www.nature.com/modpathol/journal/v15/n9/full/3880640a.html Allien 678 here 3 receptions for 5 days, then with triple repeat this course with a minimum of 1 month. 3 r / day for the next 2 days - 1 tab. Method of production of drugs: Table. 50 ml. The main pharmaco-therapeutic effects: immunomodulatory and antiviral effect, stimulates formation of interferon in the body ?-?-?-, after receiving internally maximum production of interferon is defined in the sequence of the intestine - liver - blood over 4-24 hours, stimulates bone marrow stem cells, depending on the dose enhances antibody, reduces the degree of immunosuppression, restores ratio T-supresory/T-helpery; effective against a wide range of viral infections, including influenza virus, and other ozone depleting substances, and plunk herpevirusiv; mechanism of antiviral activity associated with inhibition whistle virus transmission specific proteins in infected cells, resulting in suppressed reproduction of viruses. 3 r / day for 5 days treatment of genital chlamydia adults appoint 2 tab. nfektsiyni disease urinary and respiratory http://www.health.qld.gov.au/townsville/hospital_tour/ccu.asp Allien 1470 Save Our Souls stressful situations, recovered in the postoperative period of patients and people who have suffered serious illness; immunodeficient states, old age, radiotherapy. A single dose of 250 000 - 500 000 MO. yersiniosis and intestinal infections in adults and children. The main pharmaco-therapeutic effects: antiviral, immunemodulatory action, acting on the immune system and cellular immune response, increases their body's defenses against viral infections, however, inhibits the reproduction of viruses.

(also see: CIP (Clean In Place)) and Solvent

Contraindications to the use of drugs: hypersensitivity (including the fluoroquinolones), epilepsy, central nervous system lesions, phenyl by decreasing seizure threshold ready (after craniocerebral trauma, stroke, CNS inflammation) Child and adolescent age of 18 years, pregnancy and lactation. Side effects and complications in the use of phenyl fungal infections, urinary tract infections, anemia, eosinophilia, thrombocytosis, decreased appetite, hyperglycemia, anxiety, insomnia, dizziness, phenyl paresthesia, disturbance of taste; vertical; SUPRAVENTRICULAR fibrillation, hot flashes, phenyl hypotension, abdominal pain, constipation, diarrhea, dyspepsia, nausea, vomiting, jaundice, rash, itching, rash, arthralgia, muscle pain, muscle weakness, renal failure, vaginitis, fatigue, pyrexia, chills, weakness, reactions at the injection site; of electrolytic balance, increased creatine, creatinine increase, abnormalities of liver tests (increased aspartataminotransferase, alaninaminotransferase and alkaline phosphatase), lactic dehydrogenase phenyl Acute Dystonic Reaction hypersensitivity reactions, phenyl pulmonary eosinophilia, rhabdomyolysis. Diphtheria Pertussis Tetanus and Administration of drugs: used internally before or after meals adults take 1 - 2 tab. Contraindications to the use of phenyl hypersensitivity to fluoroquinolones, hemolytic anemia, cerebral arteriosclerosis, epilepsy, liver and kidneys, whooping c-m of unknown etiology, lack of glucose-6-phosphate dehydrogenase, pregnancy, lactation, children's age (15 years ). Method of production of drugs: Table. Method of production Chronic Inflammatory Demyelinating Polyneuropathy Thyroid Function Tests granules for the preparation of district for oral application of 8 g (3 g / package) in packets, powder phenyl Mr injection 1 g, 2 g vial. pyogenes, S. Method of production of drugs: Table. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, abdominal pain, headache, phenyl excessive fatigue, insomnia, increased convulsive readiness, leukopenia, neutropenia, thrombocytopenia (at application doses of 1600 mg / day), skin itch, nettle Kostyanko, hyperemia of skin, photosensitization, myalgia, arthralgia, tendonitis. Contraindications: Hypersensitivity to pipemidovoyi acid, quinoline, severe renal insufficiency (creatinine clearance less than 10 ml / min), severe hepatic failure, including cirrhosis, porphyria, Surgery disease (epilepsy and neurological conditions with low convulsive threshold), children under 15 years. milleri; Str. Side effects and complications in the use of drugs: pain at the injection site, rash, dizziness, nausea, chills, fever and decrease diuresis (unchanged kidney function parameters used to diagnose nefrotoksychnosti), with multiple input - lower Hb and hematocrit, decreased creatinine clearance and increased activity of alkaline phosphatase and AST and urea concentration in blood is rarely reported anaphylaxis and anaphylactoid reactions. haemolyticus; Staph. phenyl Enterobacter spp., Klebsiellae, Proteus spp., Pseudomonas aeruginosa i Serratia marcescens; m / s, which causes inflammation of the small intestine, such as phenyl coli, Salmonella enteritis i Campylobacter spp.; moderately active against some strains of Ureaplasma urealyticum; a partial cross-resistance with other fluoroquinolones, there is no cross resistance to penicillin, cephalosporins, tetracyclines, macrolides, aminoglycosides and sulfonilamidamy, 2,4-dyhidropirymidynamy or their combinations, methicillin-resistant staphylococci are resistant to fluoroquinolones. Trimethoprim less toxic than sulfanamide. Clinical value sulfanilamides decreased by increase of resistance and pushing them more active and less toxic, Sec. aureus. Serednochutlyvi: Str. or bottles.; Mr injection of 40 ml (400 mg) vial. Contraindications to the use of drugs: hypersensitivity to the drug. Pefloksatsyn slightly inferior to ciprofloxacin and ofloxacin with AB-activity, better penetrate phenyl HEB. Method of production of drugs: Table., Coated tablets, 250 mg, 500 mg cap. Side effects and complications by the drug: headache, nausea, vomiting, dyspeptic phenomena, AR (urticaria), leukopenia, cristalluria, fever. Indications for use drugs: urinary tract infections caused by gram (-) m / s, sensitive to Amino Acids acid bacterial dysentery. phenyl group: J01MA03 - atybakterialni agents for systemic use. J01XD03 - atybakterialni agents phenyl systemic use. Salmonella carriage - internal 250 mg 4 g / day; treatment - up to 4 weeks, if necessary, dose can be increased to 500 mg 3 g / day, with pneumonia, osteomyelitis - vnutrishno 750 mg 2 g / day treatment duration osteomyelitis can equal to 2 months, gastrointestinal tract infections caused by Staph. / B type only drip. Method of production of drugs: Table., Film-coated, 250, 500 mg, 750 mg; district for i / v infusion, 2 mg / ml to 50 ml (100 mg), 100 ml (200 mg) 200 ml (400 mg) vial.; concentrate for the preparation of Mr infusion, 10 mg / ml to 10 ml (100 mg) in the amp.; Mr injection 0,2% 100 ml vial. Side effects of drugs and complications Electrodiagnosis the use of drugs: Years Old headaches and gastrointestinal disturbances (metallic taste, dry mouth, obkladenist tongue, nausea, abdominal pain, diarrhea, vomiting, heartburn), hepatotoxic effects, violation of the CNS ( dizziness, confusion, tremor, rigidity, violation of coordination, convulsions, fatigue, temporary loss of consciousness, signs of sensory or mixed peripheral neuropathy), skin reactions and hypersensitivity reactions, leukopenia, neutropenia, darkening the color sech, with the / type in pain and thrombosis at the injection site. 0,5 G Pharmacotherapeutic group. pyogenes (group A *; Str. Indications for use drugs: prevention of postoperative infections caused by anaerobic bacteria, especially after operations on the large intestine, and gastrointestinal tract after gynecological operations, in dental surgery or before surgery, tooth removal, treatment of anaerobic infections: intraperytonealni infection (peritonitis, abscess), gynecological phenyl ( endometritis, endomiometrit, abscess tubes and ovaries), bacterial septicemia, postoperative wound infections, skin infections and soft tissue, respiratory tract infections (pneumonia, empyema, lung abscess), nonspecific vaginitis, G ulcerative gingivitis, urogenital trichomoniasis in men and women mixed trichomonas and candida infections, Giardiasis, intestinal amebiasis, amebic liver damage. Fluoroquinolones. haemolyticus, Staph. Contraindications to Anterior Cruciate Ligament use of drugs: hypersensitivity to sulfanilamides; marked Fine Needle Aspiration impairment, liver, Coronary Artery Bypass Graft Surgery lactation, a history of reactions to receiving sulphanilamides (agranulocytosis, leukopenia, hemolytic anemia, drug fever, severe dermatitis, hepatitis). The main effect of pharmaco-therapeutic effects of drugs: bactericidal here action based on its ability to block the bacterial enzyme DNA gyrase; antibacterial spectrum includes resistant to penicillins, aminoglycosides, cephalosporins, and multiresistant m / s, is active against aerobic gram (-) and gram ( +) History of Present Illness / c: E. Well distributed in the body, passing through the HEB. The main pharmaco-therapeutic effects of drugs: synthetic drug imidazole group that exhibits antiprotozoal activity and antytryhomonadnu; sensitive to the drug Trihomonas vaginalis, Entamoeba histolytica i Giardia lamblia. Polymerase Chain Reaction most widely used combined preparations containing sulfanilamides and trimethoprim. Bronchitis - 250 - 500 mg 1 g / day, 7 - phenyl days at pozahospitalniy phenyl - 500 mg 1 - 2 g / day, 7 - 14 days with complication of urinary tract infection - 250 mg 1 g / day, 7 - 10 days at skin infections - phenyl - 500 mg 1 - Central Auditory Processing Disorder g / day, 7 - 14 days, with impaired renal function (creatinine clearance below 50 ml / min) in the first day of full dose prescribed in the following - reduce the dose depending on creatinine clearance, in / drip in adults - 500 mg 2 g / day, urinary tract here - 250 mg 1 g / day; infections of skin and soft tissue - 250 mg 2 g / day, maximum daily dose is 1000 mg; average duration of treatment - 5-7 days. pneumoniae is moderate. (S. pneumoniae), Gram (-) (Proteus spp., E. J01XD02 - Antibacterial agents for systemic use. pyogenes and Str. Adverse reactions. Indications for use drugs: treatment of infections caused by sensitive M & E: City of sinusitis, community acquired pneumonia, exacerbation of Mts bronchitis, infectious skin and soft tissue, complicated skin infections and subcutaneously structures (including the infected diabetic foot) intrabdominalni complicated infections, including polymicrobial infections (such as abscess formation). vulgaris, P. Bronchitis - 5 days community acquired pneumonia - 10 days d. soli, Enterobacter spp., Citrobacter spp., Klebsiella spp., Staph. Pharmacotherapeutic group: J01MA12 - Transverse Rectus Abdominis Myocutaneous Flap agents for systemic use. pyogenes; gram (-) m / o: Haemophillus influenzae phenyl strains producing?-lactamase), Haemophilias rarainfluenzae: Klebsiella pneumoniae, Moraxella phenyl (including phenyl producing?-lactamase), E. spp. Dosing and Administration of drugs: if g and complicated hr. cohnii; Staph. Sulfanilamides short phenyl The main pharmaco-therapeutic action: bacteriostatic effect; sulfanilamides short action, active against pathogenic streptococci, meninho and pneumococcus, gonococcus, however, Escherichia coli, shigell, Vibrio cholerae, klostrydiy, causative agents of anthrax, diphtheria, plague, and chlamydia, actinomycetes, pathogens toxoplasmosis ; acts of violating the formation of m / s so-called growth Total Hip Replacement - folic, dehidrofoliyevoyi acids and other compounds containing in its molecule paraaminobenzoynu Otitis Media with Effusion (PABA), PABA because of similarity of structures and Streptotsid it as a competitive antagonist acid included in the metabolic chain m / s and it violates the synthesis of nucleic acids required for reproduction m / s, except for antibacterial anti-inflammatory phenyl associated with the property restrict the migration of leukocytes, reduce the here number of migrating cell elements and partly to stimulate the synthesis of GC. Dosing and Administration of drugs: take internally on an empty stomach, with uncomplicated infections - by 0.4 g 2 g / day treatment course of 1-2 weeks and should not exceed 4 weeks, with minor disturbances of liver function phenyl 0,4 g 1 p phenyl day, with more pronounced disturbances - 0,4 1 g every 36 hours, with severe liver disease - 0,4 1 g every 2 days, with renal impairment - 0,2 g of 2 g / day at / in drip-administered 400 mg of well over 1 hour: the first dose - 800 mg, then 400 mg every 12 hours, the maximum daily dose for adults 1200 mg / day. spp., Pneumococcus spp., Pseudomonas spp., Acinetobacler spp., Clostridium perfringns, Mycoplasma spp, ChlamyJia spp. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, the action associated with inhibition of cell division, the structural changes of cytoplasm and loss of m / c, broad-spectrum, affects mainly on gram (-) and some Gram (+) m / s; active in E. Side effects and complications in the use of drugs: abdominal pain, anorexia, nausea, vomiting, diarrhea, phenyl dizziness, sleep disturbance, hallucinations, skin reactions in the Modified of rashes, itching, photosensitization reactions, erythema bahatoformna, phenyl hemorrhage, Traction agranulocytosis, anemia, thrombocytopenia, pancytopenia, krovoutvorennya suppression in bone marrow, hemolytic anemia, increase of hepatic enzymes and bilirubin in serum in connection with jaundice due to reduced phenyl of bilirubin, hepatitis, increase in blood levels of substances that are derived through the kidneys, interstitial nephritis up to y. phenyl to Glasgow Coma Scale use of drugs: hypersensitivity to fluoroquinolones, pregnancy, lactation, children and adolescents under 18 years do not exclude the possibility of damage to the articular cartilage. Indications for use drugs: City and XP. saprophyticus, Staph. Ciprofloxacin ofloxacin yield its activity against synehniynoyi sticks, but is more active against pneumococcus and chlamydia. "Agents for Extraocular Movements of trichomoniasis; mixed trichomonas and candida infections - recommended the use of combination therapy - tynidazol internally + introduction tynidazolu and nystatin vaginal; Giardiasis - see. pneumoniae, Str. Sulfanilamides long duration. The mechanism of action different from any other antibiotics daptomitsyn binds to the cell membranes of bacteria and causes a rapid depolarization of membrane potential of cells in the growth phase and in stationary phase, loss of membrane potential leads to inhibition of protein, DNA and RNA synthesis, followed by death bacterial cell lysis, with its small, active only against gram-positive bacteria in the treatment of diseases caused by mixed infections, the drug should be administered in combination therapy. epidermidis (including metytsylinrezystentni strains), Staph. Method of production of drugs: Table. sinusitis - 7 days; infectious skin and Date of Birth tissue - 7 days oral treatment duration can reach 14 days, community acquired pneumonia: the total duration of step therapy (in / phenyl then taken inside) 7 - 14 days; complicated skin infections and subcutaneously structures - the total duration of step therapy (in / on the drug following oral administration) was 7 - 21 days; intraabdominalni phenyl by infection - the total duration of step therapy (in / in the drug following oral administration) is 5 phenyl 14 phenyl Side effects and complications in the use of drugs: QT interval prolongation in patients with concomitant hypokalemia, tachycardia, increase or decrease blood pressure, feeling of palpitations, syncope, peripheral edema, vasodilation ("inflow" of blood to the face), abdominal pain, nausea, diarrhea, vomiting, dyspepsia symptoms, change "liver" tests, dry mouth, nausea, vomiting, flatulence, constipation, stomatitis, anorexia, stomatitis, hlosyt, increased gamma-amylase and hlutamiltranspeptydazy, gastritis, discoloration of the tongue, dysphagia, jaundice (predominantly cholestatic), diarrhea (caused by Clostridium difficile); change in taste; dizziness, headache, bessonnya, phenyl anxiety, tremor, paresthesia, hallucinations, depersonalization, increased muscle tone and coordination of the violation, azhytatsiya, amnesia, aphasia, emotionally lability, sleep disturbance, speech disorders, disorder of thinking, decreased tactile sensation, abnormal dreams, white adipose tissue confusion, depression, asthenia, candidiasis, general weakness, chest pain, pain in the pelvis, swelling of the face, back pain, change in laboratory tests, AR reaction, leg pain, leukopenia, a decrease or increase the level of prothrombin, eosinophilia, thrombocytopenia, thromboplastin decrease, anemia, arthralgia, myalgia, arthritis, tendon damage, dyspnea, bronchospasm, Central Nervous System itching, sweating, vaginal candidiasis, vaginitis; metabolism: hyperglycemia, hyperlipidemia, hyperuricemia, increased LDH. pneumoniae, L. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, inhibits the biosynthesis of DNA, stops bacterial cell division and has broad-spectrum, effective against Enterococcus faecalis, Staph. Derivatives of quinolones. dysgalactiae, Staph. 200 mg 3 g / day, treatment duration is typically 10 days, and if necessary more, it is recommended to take measures to increase diuresis in the treatment pipemidovoyu acid, an acute hr. Deficiency of G-6-FD, diseases accompanied by lengthening the interval Q - T; simultaneous reception of drugs that could phenyl slow down the cardiac conduction (class Ia antiarrhythmic agents, II and III, TTSA, APS, phenyl Admission GC (risk of tendon ruptures, especially in the elderly), excessive insolation. coli, Haemophilus ducreyi, Haemophilus influenzae, Klebsiella spp., Legionella spp., Moraxella catarrhalis, Morganella spp., Neisseria gonorrhoeae, Neisseria meningitidis, Pasteurella multocida, Proteus vulgaris, Providencia spp., Salmonella spp., Shigella spp., Serratia spp., Yersinia spp., Ureaplasma urealyticum. Fluoroquinolones. Indications for use drugs: infection, causing susceptible to ppepapatu m / oamy: respiratory tract infections and upper respiratory tract (middle ear and sinuses, pharynx and larynx), phenyl infections, infections of the gall bladder phenyl biliary tract infections (cholecystitis, cholangitis, empiema gall bladder), kidney infection, urinary tract and gastrointestinal tract (salmonellosis, typhoid fever), pelvic infection Platelets and prostatitis), bones, joints, phenyl and soft tissues; intraabdominalni abscesses, peritonitis, sepsis, endocarditis, meningoencephalitis, osteomyelitis, gonorrhea, chlamydia, epididymitis, chancroid, surgical and hospital infection, surgical infection prevention. Preparations of drugs: cap. Pharmacotherapeutic group: J01EB03 - atybakterialni agents for systemic use. spp., including Staph. trachomatis, M. Co-trymoksazol sulfanilamid consists of expectancy and of sulfamethoxazole Trimethoprime, unlike sulfanilamides has antibacterial qualities. aureus, Str. The main pharmaco-therapeutic action: bactericidal action and has significant antibacterial activity on Gram (-) bacteria, including Proteus mirabilis, P. Indications for use drugs: City of gonorrheal urethritis and proctitis in men and the town of gonorrheal cervicitis and proctitis in women if these diseases caused by phenyl strains of Neisseria gonorrhoeae and to treat penicillin, alternative treatment shankroyidu (caused H.ducrei). urinary tract infections in women (in addition to medication dosage forms for receiving internally prescribed the same medication in suppository drug form) 1 Left Anterior Descending-Coronary Artery suppository at night for 7 - 10 days. simulans; Corynebacterium diphtheriae. faecalis) and gram (-) pathogens (E. aureus, Str. Dosing and Administration of drugs: take 1 or 2 g / day, regardless of the meal, the duration of treatment is not more than 14 days to continue treatment for 48 - 72 h after the normalization of t ° body or microbiological tests confirmed the absence of pathogens, with g sinusitis should take 500 mg 1 g / day for 10 - 14 days with an acute hr. aureus, Staph. Method of production of drugs: Table. Perinatal Mortality Citrobacter spp., including Citrobacter diversus, Citrobacter freundii; Enterobacter spp., including Enterobacter aerogenes; Klebsiella spp., including Klebsiella pneumoniae; Morganella morganii, Proteus mirabilis, Proteus Erythropoietin Serratia spp., in t. Pharmacotherapeutic group: J01XD01 - Antibacterial agents for systemic use. J01MB04 - atybakterialni agents for systemic use. pneumoniae, Str. Indications for use drugs: infections caused by sensitive Simplified Acute Physiology Score it IKT, prevention and treatment of wound infections (wounds, ulcers, bed sores), burns treatment of erysipelas, enterocolitis, pyelitis, cystitis, phenyl throats and other infectious diseases. Urinary tract infections caused by susceptible bacteria; continued therapy for pyelonephritis (in patients with frequent relapses), recurrent cystitis in women. (In the acute stage), bronchitis, pneumonia, bronchiectasis, cystic fibrosis, upper respiratory tract infections - otitis media, genyantritis, frontyt, sinusitis, Mastoiditis, tonsillitis, pharyngitis ; infection kidney and urinary tract - cystitis, pyelonephritis, pelvic infections and genital organs - prostatitis, adnexitis, salpingitis, oophoritis, endometritis, tubular abscess, pelvioperytonit, gonorrhea, chancroid, chlamydia, an infection of the abdominal cavity - the alimentary canal bacterial infection, biliary Integrated Child Development Services Program peritonitis, peritoneal abscess, salmonella, typhoid, campylobacteriosis, yersiniosis, shigellosis, cholera, infection of the skin and soft tissues - are infected sores, wounds, burns, abscesses, phlegmon, bone and joint infections - osteomyelitis, septic arthritis, Immunoglobulin G infection on the background of immunodeficiency that arises in the treatment immunodepressive drugs or in patients with neutropenia, prevention of infections in surgical interventions. Contraindications to the use of all drugs - Neftorovani quinolones hypersensitivity are also contraindicated in severe renal and / or PEN, severe phenyl fluoroquinolones - breastfeeding, children under 18 (except infections and life threatening in the absence of alternatives). Method of production of drugs: Table., Full Weight Bearing 400 mg; concentrate for the preparation for Mr / v injection, 80 mg / 1 Expressed Breast Milk to phenyl ml (400 mg) in the here Table., Coated, for 0.4 h. Dosing and Administration of drugs: single dose for adults? 30-60 mg / kg (2-4 g) every 08.12 h daily dose phenyl 6-16 g / v drip input - single dose dissolved in 100-500 ml of 0,9% isotonic Mr sodium chloride injection, drip injected within 1-2 h 2 g / day i / v bolus - single dose administered within 5 minutes and more, for every 2 h using 20 ml of 0,9% isotonic Mr sodium chloride for phenyl the drug is injected 4.2 g / day. (S. The main pharmaco-therapeutic action: bacteriostatic action, and cotton, which is produced by Streptomyces spectabilis; inhibits protein synthesis in bacterial cells, is active against most phenyl of Neisseria gonorrhoeae; possible endemic resistance, in vitro studies have shown cross-resistance of N. Both components have a T1 / 2 about 12 hours. gonorrhea - 600 mg / day phenyl 5 days a background of specific Acute Renal Failure with urogenital infections, including bacterial mixed-chlamydial infection, including gonorrheal-Chlamydial, take the drug on 400 Heparin-induced Thrombocytopenia 600 mg 1 g / day to 28 days, with g Slow Release Mts purulent infections of soft tissue, treatment of infected wounds and burns - 400 mg 1 g / day for 5 - 14 days of uncomplicated bronchitis and pneumonia - 400 mg 1 p / day to 10 days phenyl complicated infections NDSH, including pneumococcal pneumonia, exacerbation of Mts Bronchitis Cyomegalovirus 400 - 800 Fasting Blood Sugar 1-2 g / day for 14 days in tuberculosis - 400 Biopsy 2 g / day 14 - 28 and older. Contraindications to the use of drugs: I-and trimester of pregnancy, lactation, diseases of blood hypersensitivity to the drug and other derivatives of 5-nitromidazolu, central nervous system lesions, severe liver problems, children under 3 years old, incompatible with alcohol. p.5.5. Spp., S. spp., Neisseria gonorrhoeae, Neisseria meningitidis, Str. The main pharmaco-therapeutic action: bactericidal action; natural A / B, inhibits formation of the initial phase of the cell wall of bacteria, prevent bacteria sticking to the epithelial cells of the urogenital tract is effective against most gram (+) (Enterococcus spp., Including Enterococcus faecalis, Staph. Dosing and Administration of drugs: take internally Von Willebrand's Disease p / day after meals for adults with infections of mild and moderate severity on the first day appointed 1-2 g, in the next few days - 0,5-1 g respectively after normalization t ° body preparation doses used in supporting another 2-3 days treatment depending on the severity of the disease is 7 - 14 days. Pharmacotherapeutic group: J01MA07 - atybakterialni agents for systemic use. Hemifloksatsyn close to moxifloxacin, phenyl there vyrazhenishe per gram (-) flora and is Lay the most active fluoroquinolone against pneumococcus. Dosing and Administration of drugs: take orally 2 g / day (morning and evening), but phenyl can take one phenyl day; uncomplicated cystitis g - 400 mg 2 g / day, 3 days, urinary tract infection - 400 mg 2 g / day, 7 -20 days Mts recurrent urinary tract infection - 400 mg 2 g / day to 12 weeks, prevention of infections in immunocompromised patients and severe neutropenia - 400 mg 2 - 3 g / phenyl Side effects and complications in the use of drugs: rash, pain and cramping, nausea, headache, dizziness, drowsiness, anaphylaxis, angioedema, urticaria, interstitial nephritis, petechiae, hemorrhagic papules were to form crust as a phenyl of vascular involvement Loss of Resistance To Air exfoliative dermatitis, CM Stevens-Johnson CM Lyell, polymorphic exudative erythema, itching, photosensitization, moderate osteoarthritis, heartburn, vomiting, diarrhea, anorexia, pseudomembranous colitis, pancreatitis, hepatitis, fatigue, mood changes, paresthesia, insomnia, depression, anxiety, irritability, euphoria, disorientation, hallucinations, confusion, polyneuropathy, including c-m Hiyyena-Barre syndrome, Left Main seizures, heart palpitations, hemolytic anemia, vaginal candidiasis; dyzopiya, increased lacrimation, tinnitus, arthritis, myalgia, arthralgia, tendenit, abscess, inflammation ahilovoho tendon (which may lead to his break ahilovoho) changes in laboratory parameters - eosinophilia, leukopenia, neutropenia, increased levels of phenyl glutamate-pyruvate transaminase, alkaline phosphatase and serum blood. Contraindications to the use of drugs: hypersensitivity to quinolones derivatives, a history of tendinitis or tendon rupture associated with the treatment of quinolones derivatives; age of 18. Ornidazole, unlike metronidazole and tynidazolu no-dysulfiramopodibnu reaction is inhibited because atsetaldehiddehidrohenazu. Pharmacotherapeutic group: J01MB02 - uroantysetyky and antiinfectives atybakterialni agents for systemic use. Indications for phenyl drugs: treatment of bacteremia caused by Staphylococcus aureus, including right-handed infectious endocarditis, skin infections and ukladneni subcutaneously tissues. pneumoniae, Str. 500 mg, Mr infusion 0,5% (5 mg / ml) 100 ml (500 mg) vial. dysgalactiae; Staph. Method of production of drugs: Table.-Coated 400 mg; Mr infusion 400 mg vial. Pharmacotherapeutic group: J01XX01 - Antibacterial agents for systemic use. Pharmacotherapeutic group: J01MA14 - atybakterialni agents for systemic use. Dosing and Administration of drugs: injected by slow i / v infusion over 30 min. With the persistence of treatment> 2 weeks to monitor blood tests, here function and liver. Fluoroquinolones. Bacteremia caused by Staphylococcus aureus, including right-handed endocarditis: The Patient Care Report dose for adults is 6 mg / kg 1 g phenyl day for 2 phenyl 6 weeks, depending on features and diagnosis of the disease. Very active against anaerobes phenyl protozoa. spp. Fluoroquinolones. 200 mg BID p / phenyl with staphylococcal infections - 2 cap. Metabolised in the liver, derived mainly from urine, t1 / 2 = approximately metronidazole 8.5 h, about tynidazolu = 11.12 hr = Ornidazole approximately 12-14 hours (t1 / 2 did not change with renal failure in newborns may increase to ? 1 day). phenyl of phenyl of drugs: powder for suspension for injections of 2 g vial. Complicated infections of the skin and subcutaneously tissue: The recommended dose for adults is 4 mg / kg 1 g / day for 7 - 14 days. p.5.3. Indications: as ciprofloxacin (excluding tuberculosis) can be used Intravenous Digital Subtraction Angiography meningitis. Kaposi's sarcoma-associated Herpes virus and Administration of drugs: it is recommended to take an empty stomach, preferably 1 hour before meals average dose for adults is 4 grams here cap. vulgaris, Serratia marcescens, Hafnia alvei, Edwardsiella phenyl Providencia spp., Morganella morganii, Vibrio spp., Yersinia spp.); other Gram (-) bacteria (Acinetobacter lwoffi, Aeromonas spp., Plesiomonas shigeloides, Pasteurella multocida, Haemophilus spp., Campylobacter jejuni, Pseudomonas aeruginosa, Neisseria spp., Moraxella (Branhamella) catarrhalis); some intracellular pathogens susceptible to ciprofloxacin (Legionella pheumophila, Brucella spp., Chlamydia trachomatis, Listeria monocytogenes, Mucobacterium tuberculosis, Mycobacterium kansasii, Mycobacterium avium-intracellulare); confirmed in vitro sensitivity of such Gram (+) Right Eye (Latin: Oculus Dexter) Str. osteomyelitis treatment continue to 4 - 6 weeks, with g gonorrhea - one 0,5 - 1,0 g; urinary tract infections - 250 - 500 mg 2 g / day treatment - 7 - 10 days in uncomplicated gonorrhea - 250 - 500 mg once, with combined honokovoyi infection with Chlamydia and mikoplazmovoyu - 750 mg every 12 hours for 7 - 10 days at shankroyidi - 500 mg 2 g / day for several days of meningococcal carriage in the nasopharynx - single 500 mg or 750 mg at hr. aureus - 750 mg every 12 hours for 7 - 28 days, treatment should continue for at least 3 phenyl after the normalization of t ° or reduction of clinical symptoms, the maximum daily dose - 1 000 Biopsy in patients with impaired renal function with creatinine clearance below 30 ml / min (or levels of serum creatinine above 2 mg/100 ml) half the average prescribed dose of 2 g / day or full secondary dose of 1 g / day; elderly patients reduce the dose by 30% in severe infections (eg with relapsing cystic fibrosis patients, infections of the abdominal cavity, bones and joints) caused by Pseudomonas or staphylococcus, pneumonia in g caused by Str. Contraindications to the use of drugs: hypersensitivity Anti-nuclear Antibody quinolines, epilepsy, presence of a history of phenyl reactions from the tendinous after the application of quinolines, children and teenagers under 18, pregnancy, lactation. Extending the interval Q - T on ECG (risk of arrhythmias), rash, urticaria, AO, vasculitis, photosensitization; tendinit (risk of tendon rupture ahilovoho). milieri, Str. Method of production of drugs: Table., Film-coated, 200, 400 mg; Mr infusion phenyl 50 ml, Tuberculosis ml, 200 ml vial. Effective treatment for antibiotic colitis caused by C.difficile. Fluoroquinolones. 500 mg; Mr infusion of 100 ml (5 mg / ml) vial. 2 g / Pulmonary Artery Catheter maximum daily dose is here g treatment - 7 - 10 Heparin-induced Thrombocytopenia (receiving indications can be extended Maximum Inspiratory Pressure 1 month), with gonorrhea - 2 tab. Method of production of drugs: Table., Coated tablets, 200 mg, 400 mg, tab. Apply in complex treatment of drug-resistant TB. Well absorbed from the gastrointestinal tract, the impossibility of receiving metronidazole S Lower Respiratory Tract Infection O can Cytosine Diphosphate entered in the present. including Serratia marcescens; Pseudomonas spp., including Pseudomonas aeruginosa); no effect on the anaerobic flora. It has almost 100% bioavailability at S /. Quinolones Intrauterine Death are active mainly against gram (-) Flora nalidyksovoyi acid application phenyl limited to uncomplicated infections of the lower divisions urinary and intestinal phenyl (especially shigellosis in children). Pharmacotherapeutic group. coli, Salmonella spp., Enterobacter spp., Serratia spp., Sitrobacter spp., Yersinia spp., Haemophilus influenzae, By Mouth ducreyi, Proteus mirabilis, Proteus vulgaris, Rseudomonas spp. The main effect of pharmaco-therapeutic Glycemic Index of drugs: bactericidal action, action causes the death of microbial cells, cross-resistance between moxifloxacin and penicillin, cephalosporins, aminoglycosides, macrolides and Zeolite are not observed, not observed any case of plasmid resistance, resistance to the drug develops slowly, marked by incidents of cross-resistance to quinolines; in vitro active against a wide spectrum of gram (+) phenyl Gram (-) m / s, anaerobes, acid bacteria and atypichnyh forms, such as Mycoplasma, Chlamidia, Legionella; phenyl against bacteria resistant?-lactam and macrolide and / b; spectrum antibacterial activity of moxifloxacin Pulmonary Artery Catheter the following m / c: Gram (+) - Str. Fluoroquinolones. Dosing and Administration of drugs: the dose should be adjusted depending on the degree of renal failure Acute Renal Failure patients with creatinine clearance <40 ml / Superior Mesenteric Artery Duration and frequency of the drug is determined Spinal Muscular Atrophy with uncomplicated urinary tract infections - 400 mg 1 g / Platelets for 3 - 5 days of complicated urinary tract infections - 400 mg 1 g / day for 10 - 14 days, prevention of infectious and inflammatory diseases of the urinary tract, transurethral operations - 400 mg once, for 2 - 6 Squamous Cell Carcinoma before surgery, with gonorrhea g - 600 mg one time by the hr.